ALYSSA ETZKORN: Open Payments
NPI 1235780883 · PIERRE, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 35 payments from 15 companies in 2025. Trend: 2023 $638 · 2024 $909 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $159 |
| ABBVIE INC. | 3 | $66 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Novo Nordisk Inc | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Amgen Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: MOUNJARO, JOURNAVX, ELIQUIS, Ozempic, UBRELVY, TRELEGY ELLIPTA, EVENITY, QULIPTA.
Industry payments across SD — which companies pay providers there.
